GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and pursuant to the terms and conditions of each share purchase agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued. The company received conversion notices from bondholders regarding the full exercise of their conversion rights under the convertible bonds, converting convertible bonds with a principal amount of HK$1.086 billion into 5.173 billion conversion shares at a conversion price of HK$0.21 per conversion share. Accordingly, following completion of the necessary administrative procedures for the allotment of conversion shares, the company allotted and issued 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank pari passu in all respects among themselves and with all other existing shares in issue (conversion).